AMRYT PHARMA PLC's ticker is AMYT and the CUSIP is 03217L106. A total of 57 filers reported holding AMRYT PHARMA PLC in Q4 2022. The put-call ratio across all filers is 0.66 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $92,343 | +99.7% | 6,333,552 | 0.0% | 3.40% | +166.7% |
| Q4 2022 | $46,235 | -99.9% | 6,333,552 | 0.0% | 1.27% | +107.0% |
| Q3 2022 | $43,828,000 | -1.0% | 6,333,552 | 0.0% | 0.62% | -39.0% |
| Q2 2022 | $44,272,000 | -11.6% | 6,333,552 | +4.5% | 1.01% | -13.4% |
| Q1 2022 | $50,056,000 | +149.0% | 6,060,000 | +225.5% | 1.16% | +165.4% |
| Q4 2021 | $20,104,000 | +1.7% | 1,861,526 | +13.9% | 0.44% | -15.9% |
| Q3 2021 | $19,759,000 | +141.9% | 1,634,366 | +142.7% | 0.52% | +131.0% |
| Q2 2021 | $8,168,000 | -42.1% | 673,401 | -33.5% | 0.23% | -59.8% |
| Q1 2021 | $14,103,000 | +20.5% | 1,012,424 | +22.5% | 0.56% | +25.4% |
| Q4 2020 | $11,702,000 | +41.3% | 826,430 | +22.2% | 0.45% | +0.4% |
| Q3 2020 | $8,281,000 | – | 676,034 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 8,857,268 | $61,292,000 | 22.96% |
| Stonepine Capital Management, LLC | 6,227,733 | $43,096,000 | 19.37% |
| MPM ASSET MANAGEMENT LLC | 2,668,843 | $18,468,000 | 7.03% |
| Aquilo Capital Management, LLC | 1,998,993 | $13,833,000 | 4.99% |
| New Leaf Venture Partners, L.L.C. | 449,737 | $3,112,000 | 1.85% |
| Global Frontier Investments LLC | 505,000 | $3,495,000 | 1.77% |
| Rubric Capital Management LP | 3,600,000 | $24,912,000 | 1.26% |
| Telemetry Investments, L.L.C. | 123,000 | $851,000 | 1.09% |
| Nantahala Capital Management | 1,437,458 | $9,947,000 | 0.64% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 6,333,552 | $43,828,000 | 0.62% |